Aldeyra Therapeutics Inc
Aldeyra Therapeutics Inc (ALDX) Option Chain
Read more
Tracking the ALDX option chain helps you see every strike and expiry on Aldeyra Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ALDX options activity at a glance. Use our scanner to monitor the ALDX option chain in real time and filter for the trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ALDX stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ALDX options are being actively traded, and where they are not.
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma.
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 29.37 | 10 | 0 | 0.56 | 0.19 | — | 0.75 | 0.50 | -25.37 | — | 0.05 | 0.00 | 0.05 | 1 | 0 | 70.63 |
| 88.66 | 49 | 0 | 0.05 | 0.00 | — | 0.05 | 1.00 | +49.25 | 0.20 | 0.55 | 0.31 | 0.06 | 0 | 1,001 | 11.34 |
| 98.72 | 2 | 0 | 0.05 | 0.00 | — | 0.05 | 1.50 | +123.88 | 0.45 | 1.20 | 0.81 | 0.01 | 0 | 2 | 1.28 |
| 99.85 | 411 | 0 | 0.05 | 0.00 | — | 0.05 | 2.00 | +198.51 | 0.95 | 1.70 | 1.31 | 0.01 | 0 | 3 | 0.15 |
| 100.00 | 0 | 0 | 0.05 | 0.00 | — | 0.05 | 3.00 | +347.76 | 1.85 | 2.80 | 2.31 | 0.02 | 0 | 4 | 0.00 |
As of Nov 17, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV Rank71.03% High
- Market cap (M$)42
- 52 weeks high-88.36%
- 52 weeks low30.19%
- Analyst recommendationStrong Buy
1.40 - Target price$6.60
856.52% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-12
- P/E—
- Future P/E—
- EPS (ttm)-0.32
- EPS growth next 5 years38.54%
As of Nov 17, 2026